Mr. Stephen Davis reports

SUMMER 2025 SHOWS STRONG RESULTS FOR FREQUENCY EXCHANGE CORP.

Frequency Exchange Corp. has provided highlights from its summer 2025 activities, including expanded investor interest, strategic global partnerships and participation in health sector leadership forums.

"We are building a capital-efficient, IP-driven [intellectual property] platform for measurable health outcomes," said Stephen Davis, chief executive officer of Frequency Exchange. "The partnerships and distribution agreements we secured this summer signal growing confidence in the scalability and commercial strength of our frequency-based wellness platform."

Healthy America 2025

Nikki was presented at Healthy America 2025, a national gathering of health and wellness leaders, policymakers and advocates. The company was invited to participate in the Patient First National Conference, where attendees focused on reshaping the future of health in North America.

"Healthy America 2025 created a valuable forum to showcase Nikki among key public and private sector stakeholders," added Mr. Davis. "Our engagement in these types of policy-forward events demonstrates that Frequency Exchange is not only technology led but policy aware."

MG Tech partnership

Frequency Exchange signed an exclusive licence agreement with MG Tech to embed its Nikki wellness technology into Playflex, a wearable solution designed for athletic performance, in-game communication and biometric tracking.

Playflex is operated by Melvin Bratton (National Football League agent), Darin Graham (NFL trainer) and Tandon Doss (Super Bowl champion), who will join the company's advisory board. They will collaborate with Cam Neely (National Hockey League) and Dr. Keith Pyne (Major League Baseball) to support market development in the United States sports sector.

"Integrating Nikki into Playflex enhances its real-time athletic tracking with personalized wellness programming," said Mr. Davis. "This is a model for embedding our technology into performance environments with measurable need and scale potential."

Ripple distribution partnership

The company entered into a retail distribution agreement with Ripple, a channel development partner specializing in wellness products. Ripple will support retail growth in North America and international markets through structured sales programs and operational management.

"We are aligning with experienced operators who can scale our wellness offerings through proven sales infrastructure," noted Mr. Davis. "Ripple adds real-world execution strength behind our distribution strategy."

Private placement update

The company increased its previously announced non-brokered private placement from $1.5-million to $2-million. Funds will be allocated toward expansion of the management and sales teams, technology upgrades, marketing, working capital, and inventory scaling. A portion will also be used to reduce outstanding liabilities and support demand following the expansion of Fremedica's patented technology rights into general wellness applications.

Reviva partnership (Middle East)

Frequency Exchange signed a regional distribution agreement with Reviva, a firm based in United Arab Emirates specializing in health and lifestyle solutions. Nikki will become one of the first frequency-based wearable wellness technologies introduced in the Middle East.

Reviva founder Ali Nached commented, "Nikki aligns with the UAE's emphasis on innovation, aesthetic and evidence-based personal health support."

"We are seeing early traction in markets where consumers expect innovation and quality," said Mr. Davis. "Our agreement with Reviva reflects both market interest and our ability to deliver a differentiated technology that meets the demand."

About Frequency Exchange Corp.

Based in British Columbia, Canada, Frequency Exchange is publicly traded under the trading symbols FREQ on the TSX-V and FRECF on the OTC (over-the-counter) market. Frequency Exchange acquired Fremedica Technologies Inc. in 2022. Fremedica is now a wholly owned and operating subsidiary of Frequency Exchange. Fremedica's business is focused on the development and global commercialization of Nikki, a wellness technology delivering frequency-enhanced wellness programs. Nikki means "victor of the people," bringing wellness programs to all walks of life. Fremedica began with the development of a specialized Lyme support program designed to help people struggling with Lyme disease. Now, Fremedica, through Nikki, delivers wellness programs to assist with issues including sleep, pain, energy, immunity and many more. Nikki delivers wellness programs to restore and improve communication in the network of trillions of cells that make up the human body. Strong cell communication is essential to good health.

Health can be disrupted by physical, mental and emotional trauma. For example, poor sleep can be a symptom of pain, stress and fatigue stemming from poor cell communication. Nikki delivers specific frequencies into the body for the purpose of restoring proper cell function. Categories of wellness programs continue to grow. The Nikki wellness technology, combined with frequency-based wellness programs, is the result of years of development and experimentation with advanced bioenergetic technology. In third party quality-of-life testing over an eight-week period, Nikki proved to provide an unprecedented level of benefits ranging from better sleep and reduced pain to less anxiety and greater energy, with 90 per cent of the test subjects experiencing improvement in overall wellness.

We seek Safe Harbor.